Insights

This issue of Evolvalor research dives into the world of genetic engineering, specifically focusing on the deliberate (artificial) modification, manipulation, and recombination of the genetic material of an organism to change its characteristics, and its future applications and possibilities.

This paper is particularly interesting for the Biotech industry, researchers and other parties involved with the latest developments around gene-editing.

This issue of Evolvalor research covers some latest trends in the biotechnology industry, specifically focussing on the effects of the upcoming official exit of the UK from the EU (Brexit) on the industry. The Brexit may have impact on several aspects of this complex industry.

This paper is particularly interesting for the Biotech industry dealing with the upcoming Brexit in any regard, as well as for anyone requiring to dive into the impact of Brexit in this field.

This issue of Evolvalor research dives into applications of artificial intelligence (A.I.) and Machine Learning (M.L.) within the life sciences and pharmaceutical industries. We discuss the mechanisms behind A.I. and M.L., the latest trends and several applications of A.I. in the drug development value chain.

This paper provides insight into applications of A.I and M.L techniques in the Pharmaceutical industry and the underlying working mechanisms. We investigated the latest trends and fields of application in this field. This paper is particularly interesting for ICT entrepreneurs, as well as for anyone requiring to dive into this spectrum of technology.

This issue of Evolvalor market research covers insights into European Commission funding regarding Digital Health ventures within the EU. More specifically, the analysis provides insights into geographic funding location, funding preferences and funding amounts.

This paper provides insight into EU public funding preferences regarding Digital Health ventures. We investigated which countries and areas received most public EU funding. This paper is particularly interesting for Digital Health start-ups in finding suitable funding with respect to their strategy and development stage.

This issue of Evolvalor market research covers insights in VC investments within the EU regarding Digital Health ventures. More specifically, insights into VCs’ geographical location, investment preferences and investment amounts are investigated.

This paper provides insight into Venture Capital investment preferences regarding Digital Health ventures. We investigated the geographical origin of funding and which areas received most investments. This paper is particularly interesting for Digital Health start-ups and investors.

In this issue of evolvalor research we dive into the underlying principles, fields of application and drawbacks of Blockchain, Artificial Intelligence, the Internet of Things and Virtual, Augmented and Mixed Reality.

For this insight paper we investigated the latest ICT trends. It provides insights into the different trends as Blockchain, Artificial Intelligence, the Internet of Things and Virtual, Augmented and Mixed Reality, what they are and how they are already interwoven in our daily lives – or how they might be in the future. This paper is particularly interesting for ICT entrepreneurs, as well as for anyone wanting to dive into this spectrum of technology.

On this edition of Evolvalor market research we focus on eHealth financing in healthcare systems, covering financing criteria of healthcare payers and country readiness.

This insight paper covers healthcare payers financing pathways and financing criteria regarding eHealth solutions and innovations. It sheds light on the healthcare payers decision model, the tension between prevention versus current healthcare financing models and eHealth country readiness. This paper is particularly interesting for eHealth entrepreneurs in search for reimbursement and implementation, as well as other healthcare entrepreneurs.

On this edition of Evolvalor market insights we focus on the life sciences and biotechnology sector, covering Venture Capital investment preferences.

This insight paper covers Venture Capital investment preferences regarding biotechnology innovation. It sheds light on VCs’ behaviour and strategies regarding technology fields and therapeutic areas, in which they are invested most, combined with insights into investment priorities and investment barriers. This paper is particularly insightful for bioentrepreneurs, attempting to raise capital, as well as other life sciences investors.

So let’s talk

ABOUT YOUR AMBITIONS

Send us an e-mail at info@evolvalor.com or call us on +31 (0)20 24 40 317  and make sure to follow us on LinkedIn